Tag: ALSK

Blue Horseshoe Stocks: Pot Stocks Heating Up Again

Pot Stocks Still Heating Up

We have literally never stopped pounding the table on our interest in marijuana related stocks for more than five years now. While we cover something in the space practically every day, occasionally we sense a greater trend coming for the sector as a whole and issue reminders to our readers accordingly. The last such post, we published on November 9th, reminding our audience that we expected a resurgence heading into 2018, which figures to be a huge year for cannabis based business in general.

We gave a list of a handful of the symbols we routinely track which included MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, and CBIS.

GRNH and CBIS are have always been two of our favorites, although as we said, the sector as a whole will continue to be a major point of focus for us going forward. GRNH. since November 7th, has trended up from a low of .0341 to a high of .072; an increase of 111% Meanwhile, CBIS, in the same span has run from .0311 to .11, for a big 254% rise.

Some of the other fantastic moves to come out of that watchlist are as follows:

MJTK – .0005-.0028 – 460%
APHQF – 6.14-13.75 – 124%
AGTK – .0099-.0415 – 319%
ACBFF – 2.77-6.86 – 148%

These are just to name a few. Our docket of cannabis plays that we follow regularly is far too large to update all in one report, but once again, we’re going to be placing a high amount of focus on everything pot related heading into and throughout 2018.

Applied DNA Sciences, Inc. APDN

We also would like to highlight APDN, a stock that has an interesting bottom setup on the chart. As you can see on the included snapshot, the PPS has been beaten back to its lowest levels since this summer, and are hovering around a solid support level.

Couple that with the company being slated for a post-market earnings report, and we’ll be interested in tracking the activity in APDN at least through the remainder of this short week, and possibly into the upcoming short week as well.

Extended Watchlist:
ALSK, ATOS, CAG, CLNT, HMNY, WATT,

Blue Horseshoe Stocks: Options Success & More

Options Success

Netflix, Inc. NFLX – Options  -We signaled a range of options contracts on NFLX in yesterday’s premarket report, citing the earnings beat of the previous afternoon. We specifically mentioned that we were looking out for a dip-and-rip formation on the chart and the stock produced a classic example of such. NFLX’s big day, which ultimately facilitated those multi-bag profit opportunities, was fueled by an impressive 5 million new subscribers to the Netflix streaming service.

Right out of the gate, it dipped briefly to the high $175 area before going on an hours-long bullish push to the upper $184’s. That activity led to some really nice gains in our highlighted options, the NFLX Weekly $172.50-180 Calls:

$172.50 Calls – Range: 3.80-12.75 – Max Gain: 236%
$175 Calls – Range: 2.50-10.50 – Max Gain: 320%
$177.50 Calls – Range: 1.40-8.30– Max Gain: 493%
$180 Calls – Range: .85-6.42 – Max Gain: 655%

_______

Nutanix, Inc. NTNX – We also want to circle back to recap the moves made by an options idea we included in Friday morning’s report. NTNX continued to climb yesterday, and so the NTNX 7/21 $20-25 Calls we signaled have turned up some really nice moves.

$20 Calls – Range: 1.65-3.90 – Max Gain: 136%
$22.50 Calls – Range: .40-1.56 – Max Gain: 290%
$25 Calls – Range: .05-.28 – Max Gain: 460%

Yesterday’s Movers

We also had a number of the stocks that we highlighted in yesterday’s report yield chances for solid gains, and of them gave us a reason to look out for further moves:

Caprico Therapeutics, Inc. CAPR – The biggest gainer of the day from our mentions and on the NASDAQ itself, CAPR traded in a range from a low of .901, on up to a high of 1.62. That worked out to an 80% rip, and it came on an incredible 291X the monthly average volume.

The huge session was catalyzed by the announcement that the FDA has granted Rare Pediatric Disease Designation to CAP-1002, Capricor’s development candidate for the treatment of Duchenne muscular dystrophy. (>>View PR)
_________

Marijuana Company of America, Inc. MCOA – There was a nice move in MCOA as the stock traded up 38% from .02685-.037 on close to five times its monthly average volume, and the table may be set for a continuation of the trend with a new PR hitting the wires this morning.

The company is reporting that it has received the first round of funding for a joint venture to construct a 30,000 sq. ft. greenhouse grow facility in Oroville, Washington. Once completed, the greenhouse facility will accommodate a cannabis production and processing tenant with a Tier 3, I-502 license… (>>View PR)
_________

Novavax Inc. NVAX – This one recorded a very respectable gain on the day, running steadily from 1.17 up to 1.53, a 31% upswing. More importantly, the stock maintained the vast majority of its daily advance into the close, so we’ll want to continue to track NVAX as well.

Extended Watchlist:
AEZS, ALSK, NCMI, XGTI, LEXG

Blue Horseshoe Stocks: RAD, ACHN Recaps & More

Achillon Pharmaceuticals, Inc. ACHN

ACHN stood out amongst the stocks we discussed in yesterday’s morning report. The move came in conjunction with the announcement that the company’s Hep C treatment currently in trials had successfully cured all of the patients in the latest clinical test.

As a result ACHN ran from a morning low of 14.56 on up to 16.87 for a solid 16% intraday move, on its highest volume traded since June.

We’ve been tracking ACHN for over a month now, and in that time have observed a low of 12.00 (Nov. 12th). As of yesterday’s high, that represents an overall increase of 40% in a relatively short amount of time.

Rite-Aid Corp. RAD

We began paying attention to RAD on Tuesday of last week, and the stock has made some good progress since then. Yesterday was no exception, with RAD adding another 6% to the healthy upward movements we’ve already witnessed.

From the low of 5.79 we observed last Tuesday after adding it to our watchlist for the first time, to yesterday’s high of 7.19, equates to a move of 25% in a span of just five sessions. That’s more than enough to hold our attention as we head into the New Year.

It’s worth mentioning that the Cowen Group investment research arm upgraded RAD from a ‘Neutral’ to an ‘Outperform’ rating, with a price target of 8.50/share, and one of our favorite sites, BARCHART.com is currently rating RAD a 100% Short-Term ‘Buy’, with an 88% ‘Buy’ Rating overall.

Extended Watchlist:
NQ, ARIA, ALSK, CYTK, ICLD, DRYS